The US president vows "major" tariffs on imported medicines - raising fears of an increase in costs for Americans.

Drugmakers' stocks in Europe and India slipped on Wednesday after U.S. President Donald Trump reiterated plans for a "major" ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Novo Nordisk and Sanofi were among companies threatening to hasten their exits to the U.S., as Trump promised pharma tariffs ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary ...

An exploratory analysis shows a reduction in extrathoracic metastases and prolonged time to progression or death due to any ...

The pharmaceutical company says it will continue to operate its production facility near Research Triangle Park.

Novartis is thriving with double-digit growth, driven by key drugs in oncology, cardiology, immunology, and neurology. See ...

North Carolina economic development officials terminated several incentives grants this week, including some tied to ...

Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...

When Novartis bought kidney disease biotech Chinook Therapeutics in 2023 for $3.2 billion upfront, the deal included a ...